Subscribe
Dan Jones explains what an American quality share should look like in an era when AI dominates the S&P 500
It faces threats, but there are reasons why the Sage of Omaha has owned this stock for 25 years
Its weight-loss drugs are more accessible, and it has secured tariff exemptions
Investors will need deep pockets to take a stake in this prodigious compounder, but it’s worth it
Its shares are down due to macro worries, but the company is quickly moving to a less cyclical model
Esteemed economist Nouriel Roubini, who sports the nickname ‘Dr Doom’, is predicting a brighter future
The AI narrative is starting to change, but there are still plenty of optimists out there
Robinhood is riding the wave in the US amid hot competition, while UK leveraged trading platforms make headway
An affordability crisis is pressuring property stocks across the Atlantic, but not all parts of the sector are suffering equally
The Squeeze: Market gains since ChatGPT was released do not suggest a high likelihood of success
